logo
  

Renault Plans Cut Up To 2,000 Jobs In France

Renault Group management and representative trade unions launched negotiations with a view to concluding a nationwide multi-year labor agreement for the period 2022-2024.
The French carmaker would cut up to 2,000 jobs in France and create new jobs.

Renault Group said it plans to produce nine new vehicle models in France by 2025.

The project would involve 2,500 new recruitments for a net increase of 500 jobs and provide 10,000 training and professional reorientation initiatives spanning all occupations.

The company reaffirmed its commitment to position France at the heart of its industrial and R&D activities by establishing future-oriented and value-creating technologies in the country.

The company noted that it will create 2,000 new jobs in its French plants. It would also implement more than 5,000 training and professional reorientation programs to help workers develop skills suited to the automotive industry's new value chain.

Renault Group said, to ensure engineering capabilities, it must continue tailoring its workforce, with the possibility of 1,600 departures. At the same time, the Group would create 400 jobs centered on new key skills such as data sciences and battery chemistry, while also implementing 3,000 training and professional reorientation initiatives.

Renault Group presented a plan to refocus support functions, with 400 potential departures in France. The goal would be to modernize and digitalize these functions with a renewed emphasis on value-added activities, in accordance with the Group's strategic objectives.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Privately-held biotechnology company On Target Laboratories, Inc. announce that the U.S. Food and Drug Administration or FDA, has approved Cytalux (pafolacianine) for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions. Cytalux is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively. The Federal Trade Commission or FTC has ordered Walmart, Amazon, Kroger and certain other large wholesalers and suppliers to provide information to help it study causes of supply chain disruptions. The agency has launched an inquiry to find the reasons for empty shelves and exorbitant prices. Along with Walmart, Amazon.com, and Kroger, the order has been sent to C&S Wholesale Grocers, Associated.. Covid vaccine maker Moderna Inc.'s Chief Executive Stéphane Bancel has predicted that existing COVID-19 vaccines will be much less effective against Omicron than earlier strains, according to the Financial Times.
Follow RTT